共 50 条
Interpretation of NCCN Guideline: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Version 1, 2017)
被引:0
|作者:
Xia Lei
[1
]
Tang Yan
[1
]
Xu Xin-yu
[1
]
Zhu Miao-lin
[1
]
机构:
[1] Jiangsu Canc Hosp, Dept Pathol, Nanjing 210009, Jiangsu, Peoples R China
来源:
关键词:
National Comprehensive;
Cancer Network;
Chronic lymphocytic leukemia;
Small lymphocytic lymphoma;
Monoclonal B lymphocytosis;
D O I:
10.11910/2227-6394.2016.04.04.11
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Chronic lymphocytic leukemia (CLL) is a kind of chronic lymphocyte proliferative disease with corresponding clinical symptoms caused by the accumulation of mature B lymphocytes in peripheral blood, bone marrow and lymphatic tissues. In recent years, great achievements have been reached on the basic research, new prognostic markers, diagnostic criteria and therapeutic methods in CLL. This study mainly interpreted the corresponding diagnosis and treatment of CLL in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines (R)): Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Version 1, 2017).
引用
收藏
页码:287 / 292
页数:6
相关论文